Imatinib in combination with cytarabine as compared to imatinib alone in patients with first chronic phase chronic myeloid leukemia. A prospective randomised phase III study.

Trial Profile

Imatinib in combination with cytarabine as compared to imatinib alone in patients with first chronic phase chronic myeloid leukemia. A prospective randomised phase III study.

Completed
Phase of Trial: Phase III

Latest Information Update: 16 Aug 2014

At a glance

  • Drugs Cytarabine; Imatinib
  • Indications Chronic myeloid leukaemia
  • Focus Therapeutic Use
  • Acronyms HOVON-78-CML
  • Most Recent Events

    • 16 Aug 2014 New source identified and integrated (European Clinical Trials Database record:EudraCT2005-003839-41)
    • 01 Oct 2013 According to the European Clinical Trials database record, trial status is completed.
    • 01 Aug 2013 Results published in the Annals of Hematology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top